Cysteinyl leukotriene levels correlate with 8-isoprostane levels in exhaled breath condensates of atopic and healthy children

Pediatric Research

Volumn 74, Issue 5, 2013, Pages 584-591

  Wan, Gwo Hwa ^a   Yan, Dah Chin ^a,b,c   Tseng, Hui Yun ^d   Tung, Tao Hsin ^e   Lin, Syh Jae ^a,b   Lin, Yu Wen ^f  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^f FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; PEPTIDOLEUKOTRIENE;

ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPY; AUTUMN; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXHALED BREATH CONDENSATE; FEMALE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT PARAMETERS; SCHOOL CHILD; SEASON; SPRING; SUMMER; WINTER;

BREATH TESTS; CHILD; CYSTEINE; DINOPROST; HUMANS; LEUKOTRIENES; LINEAR MODELS; OXIDATIVE STRESS; RESPIRATORY FUNCTION TESTS; RESPIRATORY HYPERSENSITIVITY; SEASONS; TAIWAN;

EID: 84887478154     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2013.142     Document Type: Article

References (39)

1. Kao CC, Huang JL, Ou LS, See LC. The prevalence, severity and seasonal variations of asthma, rhinitis and eczema in Taiwanese schoolchildren. Pediatr Allergy Immunol 2005;16:408-15.
2. Liao MF, Huang JL, Chiang LC, Wang FY, Chen CY. Prevalence of asthma, rhinitis, and eczema from ISAAC survey of schoolchildren in Central Taiwan. J Asthma 2005;42:833-7.
3. Brozek JL, Bousquet J, Baena-Cagnani CE, et al.; Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010;126:466-76.
4. Profita M, Montuschi P, Bonanno A, et al. Novel perspectives in the detection of oral and nasal oxidative stress and inflammation in pediatric united airway diseases. Int J Immunopathol Pharmacol 2010;23:1211-9.
5. Kostikas K, Koutsokera A, Papiris S, Gourgoulianis KI, Loukides S. Exhaled breath condensate in patients with asthma: implications for application in clinical practice. Clin Exp Allergy 2008;38:557-65.
6. Samitas K, Chorianopoulos D, Vittorakis S, et al. Exhaled cysteinyl-leukotrienes and 8-isoprostane in patients with asthma and their relation to clinical severity. Respir Med 2009;103:750-6.
7. Shahid SK, Kharitonov SA, Wilson NM, Bush A, Barnes PJ. Exhaled 8-isoprostane in childhood asthma. Respir Res 2005;6:79.
8. Montuschi P, Ragazzoni E, Valente S, et al. Validation of 8-isoprostane and prostaglandin E(2) measurements in exhaled breath condensate. Inflamm Res 2003;52:502-7.
9. Cruz MJ, S?chez-Vidaurre S, Romero PV, Morell F, Mu?z X. Impact of age on pH, 8-isoprostane, and nitrogen oxides in exhaled breath condensate. Chest 2009;135:462-7.
10. Montuschi P, Barnes PJ. Isoprostanes and asthma. Drug Discov Today Ther Strat 2006;3:287-292.
11. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999;160:216-20.
12. Zhao JJ, Shimizu Y, Dobashi K, et al. The relationship between oxidative stress and acid stress in adult patients with mild asthma. J Investig Allergol Clin Immunol 2008;18:41-5.
13. Baraldi E, Carraro S, Alinovi R, et al. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 2003;58:505-9.
14. Carraro S, Cogo PE, Isak I, et al. EIA and GC/MS analysis of 8-isoprostane in EBC of children with problematic asthma. Eur Respir J 2010;35:1364-9.
15. Hasan RA, Thomas J, Davidson B, Barnes J, Reddy R. 8-Isoprostane in the exhaled breath condensate of children hospitalized for status asthmaticus. Pediatr Crit Care Med 2011;12:e25-8.
16. Montuschi P, Mondino C, Koch P, Barnes PJ, Ciabattoni G. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma. J Allergy Clin Immunol 2006;118:347-53.
17. Morera AL, Intxausti A, Abreu-Gonzalez P. Winter/summer seasonal changes in malondialdehyde formation as a source of variance in oxidative stress schizophrenia research. World J Biol Psychiatry 2009;10(4 Pt 2):576-80.
18. Konior A, Klemenska E, Brudek M, Podolecka E, Czarnowska E, Beresewicz A. Seasonal superoxide overproduction and endothelial activation in guinea-pig heart; seasonal oxidative stress in rats and humans. J Mol Cell Cardiol 2011;50:686-94.
19. Barnes PJ. Pathophysiology of asthma. Br J Clin Pharmacol 1996;42:3-10.
20. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001;344:350-62.
21. Failla M, Biondi G, Provvidenza Pistorio M, et al. Intranasal steroid reduces exhaled bronchial cysteinyl leukotrienes in allergic patients. Clin Exp Allergy 2006;36:325-30.
22. Csoma Z, Kharitonov SA, Balint B, Bush A, Wilson NM, Barnes PJ. Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2002;166:1345-9.
23. Mondino C, Ciabattoni G, Koch P, et al. Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children. J Allergy Clin Immunol 2004;114:761-7.
24. Tufvesson E, Bjermer L. Methodological improvements for measuring eicosanoids and cytokines in exhaled breath condensate. Respir Med 2006;100:34-8.
25. Montuschi P, Barnes PJ. Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol 2002;109:615-20.
26. Antczak A, Montuschi P, Kharitonov S, Gorski P, Barnes PJ. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am J Respir Crit Care Med 2002;166:301-6.
27. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143-78.
28. Canonica GW, Compalati E. Minimal persistent inflammation in allergic rhinitis: implications for current treatment strategies. Clin Exp Immunol 2009;158:260-71.
29. Passalacqua G, Canonica GW. From minimal persistent inflammation to continuous treatment. Eur Respir Dis 2006;34-5.
30. Peters-Golden M, Gleason MM, Togias A. Cysteinyl leukotrienes: multifunctional mediators in allergic rhinitis. Clin Exp Allergy 2006;36:689-703.
31. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990;323:645-55.
32. Montuschi P, Barnes P, Roberts LJ 2nd. Insights into oxidative stress: the isoprostanes. Curr Med Chem 2007;14:703-17.
33. Zanconato S, Carraro S, Corradi M, et al. Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma. J Allergy Clin Immunol 2004;113:257-63.
34. Borrill ZL, Starkey RC, Singh SD. Variability of exhaled breath condensate leukotriene B4 and 8-isoprostane in COPD patients. Int J Chron Obstruct Pulmon Dis 2007;2:71-6.
35. Grob NM, Aytekin M, Dweik RA. Biomarkers in exhaled breath condensate: a review of collection, processing and analysis. J Breath Res 2008;2:037004.
36. Debley JS, Ohanian AS, Spiekerman CF, Aitken ML, Hallstrand TS. Effects of bronchoconstriction, minute ventilation, and deep inspiration on the composition of exhaled breath condensate. Chest 2011;139:16-22.
37. Esther CR Jr, Lazaar AL, Bordonali E, Qaqish B, Boucher RC. Elevated airway purines in COPD. Chest 2011;140:954-60.
38. Cervenak L, Orosz M, et al. Adenosine triphosphate concentration of exhaled breath condensate in asthma. Chest 2010;138:536-42.
39. Kwok MY, Walsh-Kelly CM, Gorelick MH, Grabowski L, Kelly KJ. National Asthma Education and Prevention Program severity classification as a measure of disease burden in children with acute asthma. Pediatrics 2006;117(4 Pt 2):S71-7.